Skip to content
MarketScale
‹ Back to IndustriesHealthcare

Intellego: Expert Advice for Choosing and Using UV-C Disinfection Systems for Your Facility

“Deploying UV-C technology requires meeting facility needs and ensuring they know how to use it and validate it that it’s working properly.” Disinfection is at the forefront of everyone’s mind in a pandemic. As a result, most facilities need a portfolio of tools to support this, with UV-C being one of those. But how can…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share
Intellego: Expert Advice for Choosing and Using UV-C Disinfection Systems for Your Facility

Get featured

Want to get featured in MarketScale Healthcare?

Create a free MarketScale workspace and get your company's expertise featured across our Healthcare coverage. No credit card, no demo required.

Request an invite

“Deploying UV-C technology requires meeting facility needs and ensuring they know how to use it and validate it that it’s working properly.”

Disinfection is at the forefront of everyone’s mind in a pandemic. As a result, most facilities need a portfolio of tools to support this, with UV-C being one of those. But how can organizations implement it and ensure it’s working? In this discussion, host Daniel Litwin spoke to two subject matter experts, Wendy Brady-Walling, Director of Global Marketing, Intellego Technologies, and Christine Gallo, CEO, Gallo Medical Company and IP Program.

Gallo, already in the medical industry, became a bigger advocate for infection prevention and disinfection after a family member’s health battle. “I realized we have to do better, and that’s what led me to add UV-C to the toolbox to help with this,” she said.

Gallo’s objective now is to partner with facilities to help them find funding to acquire and deploy UV-C disinfection systems and ensure it’s working by using UV-C dosimeters, which provide visual validation of disinfection. She noted that dosimeters are included in the purchase of the UV-C equipment and that her team trains staff on how to use them.

Brady-Walling discussed the many delivery systems of UV-C, from mobile towers to ceiling mounts to autonomous robots. “Pre-COVID, UV-C disinfection systems were considered ‘nice to have.’ Now they’re a ‘need to have.’ That’s why we’re focused on educating industries about its availability, safety, efficacy, and efficiency.”

The pandemic also meant using UV-C in new spaces, including restaurants, airports, gyms, and office buildings. In the healthcare setting, UV-C was in use in operating rooms. “They are using it in patient rooms prior to staff cleaning, so it’s safer for them. We just deployed it at a cancer center.”

Brady-Walling added, “They love the technology and the visual evidence from the dosimeter that it was a successful disinfection.”

Follow us on social media for the latest updates in B2B!

Twitter – @MarketScale

Facebook – facebook.com/marketscale

LinkedIn – linkedin.com/company/marketscale

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Get your team featuredSee how it works15 minutes, straight to a calendar.

Follow Healthcare Insights

Get new expert content in your inbox.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

Cleveland Clinic’s 900-person AI summit signals a new buying cycle for patient portals

Cleveland Clinic’s 900-person AI summit signals a new buying cycle for patient portals

Cleveland Clinic hosted a significant AI Summit attended by 900 people, indicating a shift towards adopting AI in various healthcare operations. The Summit, along with a $50 million access initiative, highlights the integration of AI in processes such as routing, documentation, and bed-flow systems. This move signals a new buying cycle for patient portals in the healthcare industry.

  • 01Cleveland Clinic hosted a 900-person AI Summit signaling AI's integration into healthcare operations.
  • 02A $50 million access initiative emphasizes the application of AI in systems like routing and documentation.
  • 03Patient portals are entering a new buying cycle due to advancements in AI technology.

Aug 31, 2026

Medicare sets $137.53 maximum add-on payment per eligible inpatient case for CT triage AI

Medicare sets $137.53 maximum add-on payment per eligible inpatient case for CT triage AI

Medicare has announced a maximum add-on payment of $137.53 per eligible inpatient case for the use of AI in CT triage, utilizing Aidoc’s CT Body triage technology. This move emphasizes the importance of workflow integration, governance, and coding in hospitals employing radiology AI. The new technology add-on payment (NTAP) signifies a clear investment in AI-driven healthcare solutions.

  • 01Medicare introduces a $137.53 per-case payment for AI in CT triage.
  • 02Hospitals must integrate AI with proper workflow, governance, and coding.
  • 03The NTAP reflects investment in radiology AI solutions.

Aug 30, 2026

Rasonque’s 13.2-month survival result is about to hit hospital formularies

Rasonque’s 13.2-month survival result is about to hit hospital formularies

FDA has cleared Revolution Medicines' drug Rasonque for treating metastatic pancreatic adenocarcinoma. Hospitals are now integrating this drug into their formularies, focusing on operations like pathways, genotyping, and specialty pharmacy flow.

  • 01Rasonque has received FDA clearance for treating metastatic pancreatic adenocarcinoma.
  • 02Hospitals are working on integrating Rasonque into their formularies.
  • 03Operational focus includes pathways, genotyping, and specialty pharmacy flow.

Aug 30, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512